Newsfiscal.ai
Unified Patent Court Rules Enanta Pharmaceuticals' '265 Patent Invalid in Pfizer Litigation
· Published
Article summary
The Unified Patent Court has ruled that Enanta Pharmaceuticals' '265 patent is invalid as part of an ongoing patent infringement action against Pfizer.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…